INFLUENCE OF SEX, MENSTRUAL CYCLE AND ORAL CONTRACEPTION ON THE DISPOSITION OF NITRAZEPAMJOCHEMSEN R; VAN DER GRAAFF M; BOEIJINGA JK et al.1982; BR. J. CLIN. PHARMACOL.; ISSN 0306-5251; GBR; DA. 1982; VOL. 13; NO 3; PP. 319-324; BIBL. 21 REF.Article

An unusual cause of epilepsy and mental deteriorationVAN DER GRAAFF, M; DAVIES, G.British journal of radiology. 2002, Vol 75, Num 896, pp 709-710, issn 0007-1285Article

Unilateral thalamic infarction and vertical gaze palsy : Cause or coincidence?VAN DER GRAAFF, M. M; VANNESTE, J. A. L; DAVIES, G. A. A. G et al.Journal of neuro-ophthalmology. 2000, Vol 20, Num 2, pp 127-129, issn 1070-8022Article

Disposition of hexobarbital enantiomers in the ratVAN DER GRAAFF, M; VERMEULEN, N. P. E; JOERES, R. P et al.Drug metabolism and disposition. 1983, Vol 11, Num 5, pp 489-493, issn 0090-9556Article

Disposition of hexobarbital: 15 years of an intriguing model substrateVAN DER GRAAFF, M; VERMEULEN, N. P. E; BREIMER, D. D et al.Drug metabolism reviews (Softcover ed.). 1988, Vol 19, Num 2, pp 109-164, issn 0360-2532Article

Route- and dose-dependent pharmacokinetics of hexobartitone in the rat: a re-evaluation of the use of sleeping times in metabolic studiesVAN DER GRAAFF, M; VERMEULEN, N. P. E; BREIMER, D. D et al.Journal of pharmacy and pharmacology. 1985, Vol 37, Num 8, pp 550-554, issn 0022-3573Article

Correlation of apparent intrinsic clearances of simultaneously administered S (+) and d₃ R (-) hexobarbital in the ratVAN DER GRAAFF, M; VERMEULEN, N. P. E; HOFMAN, P. H et al.Biochemical pharmacology. 1987, Vol 36, Num 8, pp 1321-1323, issn 0006-2952Article

Non-linear pharmacokinetics of sparteine in the ratVAN DER GRAAFF, M; VERMEULEN, N. P. E; KOPERDRAAT, M. C et al.Archives internationales de pharmacodynamie et de thérapie. 1986, Vol 282, Num 2, pp 181-195, issn 0003-9780Article

The influence of pretreatment on the urinary metabolite profile of pseudoracemic hexobarbitalVAN DER GRAAFF, M; VERMEULEN, N. P. E; HOFMAN, P. H et al.Biochemical pharmacology. 1986, Vol 35, Num 18, pp 3166-3169, issn 0006-2952Article

Stereospecific analysis of racemic hexobarbital in rat blood by enantioselective capillary gas chromatographyVAN DER GRAAFF, M; VERMEULEN, N. P. E; HOFMAN, P. H et al.Journal of chromatography. 1986, Vol 375, Num 2, pp 411-415, issn 0021-9673Article

Dose-dependent pharmacokinetics of zoxazolamine in the ratVAN DER GRAAFF, M; VERMEULEN, N. P. E; CRUL, I. E. P et al.Drug metabolism and disposition. 1986, Vol 14, Num 3, pp 331-335, issn 0090-9556Article

Correlation between the metabolism of hexobarbital and aminopyrine in vivo in ratsVAN DER GRAAFF, M; VERMEULEN, N. P. E; HEIJ, P et al.Xenobiotica (London. Print). 1986, Vol 16, Num 12, pp 1091-1096, issn 0049-8254Article

Selected ion monitoring analysing of pseudoracemic hexobarbital and its major metabolites in blood and urine of ratsVAN DER GRAAFF, M; HOFMAN, P. H; BREIMER, D. D et al.Biomedical mass spectrometry. 1985, Vol 12, Num 9, pp 464-469, issn 0306-042XArticle

Correlation between the in vivo metabolism of hexobarbital and antipyrine in ratsVAN DER GRAAFF, M; VERMEULEN, N. P. E; JOERES, R. P et al.The Journal of pharmacology and experimental therapeutics. 1983, Vol 227, Num 2, pp 459-465, issn 0022-3565Article

Disposition of allylic oxidation pathway metabolites of racemic hexobarbital in the ratVAN DER GRAAFF, M; VERMEULEN, N. P. E; VINKS, M. H. A. M et al.European journal of drug metabolism and pharmacokinetics. 1986, Vol 11, Num 2, pp 107-111, issn 0378-7966Article

Multidisciplinary ALS care improves quality of life in patients with ALSVAN DEN BERG, J. P; KALMIJN, S; LINDEMAN, E et al.Neurology. 2005, Vol 65, Num 8, pp 1264-1267, issn 0028-3878, 4 p.Article

MR Spectroscopy Findings in Early Stages of Motor Neuron DiseaseVAN DER GRAAFF, M. M; LAVINI, C; AKKERMAN, E. M et al.American journal of neuroradiology. 2010, Vol 31, Num 10, pp 1799-1806, issn 0195-6108, 8 p.Article